Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEPTA Trial: Stockholm3 Validation Study in a Multi-Ethnic Cohort for ProsTAte Cancer

NCT04583072 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT04583072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04583072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEPTA Trial: Stockholm3 Validation Study in a Multi-Ethnic Cohort for ProsTAte Cancer
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
December 15, 2019
Completion date
July 15, 2023
Enrollment
2,152 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (diagnosis)